Simon Tiberi

7 ta ish

Queen Mary University of London

1. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

   Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman +97

   Sharh maqolaOAOchiq kirish20184 iqtibos

   ABIABI:AkademIndex/2026.other.034216

2. Faster for less: the new “shorter” regimen for multidrug-resistant tuberculosis

   Giovanni Sotgiu, Simon Tiberi, Lia D’Ambrosio +18

   BoshqaOAOchiq kirish20163 iqtibos

   ABIABI:AkademIndex/2026.other.027997

3. Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts

   Jeremiah Chakaya, Mishal Khan, Francine Ntoumi +14

   Maqola20213 iqtibos

   ABIABI:AkademIndex/2026.other.594397

4. WHO recommendations on shorter treatment of multidrug-resistant tuberculosis

   Giovanni Sotgiu, Simon Tiberi, Lia D’Ambrosio +3

   MaqolaOAOchiq kirish20162 iqtibos

   ABIABI:AkademIndex/2026.other.027996

5. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

   Simon Tiberi, Nelita du Plessis, Gerhard Walzl +11

   Sharh maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.360228

6. New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis

   Denise Rossato Silva, Margareth Pretti Dalcolmo, Simon Tiberi +9

   Sharh maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.360229

7. Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings

   Giovanni Sotgiu, Simon Tiberi, Rosella Centis +4

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.360273